EGF Receptor Mabs and Chemotherapy in Breast Cancer.

Abstract

To establish a safety profile in patients with Stage IV, EGFr positive breast cancer, for which no curative standard exists, of C225 over a range of dose levels and to pharmacologically optimize the dosing regimen of loading and maintenance infusions administered during combination chemotherapy with weekly doses of paclitaxel.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1996
Accession Number
ADA328029

Entities

People

  • Andrew Seidman
  • Larry Norton

Organizations

  • Memorial Sloan Kettering Cancer Center

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Animals
  • Biomedical Research
  • Breast Cancer
  • Chemotherapy
  • Classification
  • Deoxyribonucleic Acids
  • Federal Law
  • Information Operations
  • Laboratory Animals
  • Materials
  • Molecules
  • Neoplasms
  • New York
  • Recombinant Dna
  • Standards

Readers

  • Oncology (Cancer Research).